Product Information
ARMODAFINIL 250 MG TABLET is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.9082 per EA under NDC 00378343393. Its NADAC has been published 524 times since Sep 21, 2016.
FDA first approved this application on Jun 1, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
250 mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
00378343393
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ARMODAFINILApproval Type
Generic (ANDA)
FDA Application
ANDA200043FDA Approved
6/1/2012
TE Code
AB
On Market Since
6/1/2016
Price Statistics
The NADAC for ARMODAFINIL 250 MG TABLET has been published 524 times since Sep 21, 2016, and over the history we have for it it has declined 94.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.9082 per EA |
|---|---|
| All-time high | $17.3931 (Dec 14, 2016) |
| All-time low | $0.6325 (Nov 20, 2024) |
| 52-week high | $0.9673 |
| 52-week low | $0.9011 |
| Median price | $1.0376 |
| Average price | $1.7544 |
| Largest weekly change | -86.6% (Feb 22, 2017) |
| Weeks tracked | 524 |
| Tracking since | Sep 21, 2016 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the armodafinil market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Mylan Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
armodafinil market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ARMODAFINIL 250 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ARMODAFINIL 250 MG TABLET, manufactured by Mylan Pharmaceuticals Inc., is $0.9082 per EA (NDC 00378343393), effective Sep 30, 2026.
How has the price of ARMODAFINIL 250 MG TABLET changed over time?
Over the history we have for it, the NADAC for ARMODAFINIL 250 MG TABLET has declined 94.7%. It has been tracked across 524 weekly CMS publications since Sep 21, 2016.
What are the highest and lowest recorded NADAC prices for ARMODAFINIL 250 MG TABLET?
Since Sep 21, 2016, the NADAC for ARMODAFINIL 250 MG TABLET has ranged from a low of $0.6325 (Nov 20, 2024) to a high of $17.3931 (Dec 14, 2016), with a median of $1.0376 per EA.
Are there cheaper alternatives to ARMODAFINIL 250 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of ARMODAFINIL 250 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ARMODAFINIL 250 MG TABLET?
ARMODAFINIL 250 MG TABLET (NDC 00378343393) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.